Prestige Consumer Healthcare (PBH) Change in Accured Expenses (2010 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Change in Accured Expenses came in at $2.4 million in Q4 2025, down 35.5% year-on-year from $3.8 million in Q4 2024, and down 48.59% quarter-over-quarter from $4.7 million in Q3 2025.

Prestige Consumer Healthcare (PBH) Change in Accured Expenses (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Change in Accured Expenses history runs 16 years deep, the most recent figure standing at $2.4 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 35.5% year-over-year to $2.4 million in Q4 2025; TTM through Dec 2025 was $9.0 million, a 317.72% increase from a year earlier, with the FY2025 full-year figure at $7.0 million, up 143.07% from the prior year.
  • Change in Accured Expenses eased to $2.4 million in Q4 2025 per PBH's latest filing, from $4.7 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $18.4 million in Q2 2021 and bottomed at -$23.1 million in Q1 2021.
  • The 5-year median for Change in Accured Expenses is $830500.0 (2022), against an average of -$283250.0.
  • Across the five-year window, Change in Accured Expenses jumped 379.42% in 2023 and plunged 453.98% in 2024, its largest moves.
  • Year by year, Change in Accured Expenses stood at -$9.5 million in 2021, then soared by 84.84% to -$1.4 million in 2022, then soared by 379.42% to $4.0 million in 2023, then fell by 6.37% to $3.8 million in 2024, then sank by 35.5% to $2.4 million in 2025.
  • Per Business Quant, the three latest PBH Change in Accured Expenses figures stand at $2.4 million (Q4 2025), $4.7 million (Q3 2025), and -$813000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Prestige Consumer Healthcare 2.41 Bn 2.35 Bn 157.37 Mn 2.44 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.44 Mn
Dec 31, 2025 2.44 Mn
Sep 30, 2025 4.74 Mn
Sep 30, 2025 4.74 Mn
Jun 30, 2025 -813,000.00
Jun 30, 2025 -813,000.00
Mar 31, 2025 2.63 Mn
Mar 31, 2025 2.63 Mn
Dec 31, 2024 3.78 Mn
Dec 31, 2024 3.78 Mn
Sep 30, 2024 2.65 Mn
Sep 30, 2024 2.65 Mn
Jun 30, 2024 -2.06 Mn
Jun 30, 2024 -2.06 Mn
Mar 31, 2024 -8.49 Mn
Mar 31, 2024 -8.49 Mn
Dec 31, 2023 4.03 Mn
Dec 31, 2023 4.03 Mn
Sep 30, 2023 -3.25 Mn
Sep 30, 2023 -3.25 Mn